Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults NHLBI Obesity Education Initiative National Heart,

Slides:

Advertisements

Similar presentations

The Burden of Obesity in North Carolina Overview.

Advertisements

Guidelines for the Primary Prevention of Stroke. A Guideline for Healthcare Professionals From the American Heart Association & American Stroke Association.

Summary Prepared by Melvyn Rubenfire, MD

© 2008, American Heart Association. All rights reserved. AHA 2008 Resistant Hypertension: Diagnosis, Evaluation, and Treatment Slide Set David A. Calhoun,

NCEP ATP IV GuidelineS: 2013 Update

Advances in Lipid Management. The National Cholesterol Education Program (NCEP)  Launched by National Heart, Lung, and Blood Institute (NHLBI), a part.

American College of Chest Physicians (ACCP) Health and Science Policy Committee Orientation Program Part #1 General Overview and Structure.

Definitions Body Mass Index (BMI) describes relative weight for height: weight (kg)/height (m 2 ) Overweight = 25–29.9 BMI Obesity = >30 BMI.

10 Points to Remember for the Management of Overweight and Obesity in Adults Management of Overweight and Obesity in Adults Summary Prepared by Elizabeth.

SUPERSIZED NATION By Jennifer Ericksen August 24, 2007.

Physical Activity and Weight Loss ACSM, Weight Gain Physical activity will prevent weight gain – PA of 150 to 250 min. wk -1 with an energy equivalent.

Part 1: Frustrated with Obesity Management? 5210 & Motivational Interviewing to the Rescue! Jamie Jeffrey, MD, FAAP Medical Director, Children’s Medicine.

1 Background Hypertension Type 2 diabetes Coronary heart disease Gallbladder disease Certain cancers Dyslipidemia Stroke Osteoarthritis Sleep apnea Approximately.

NCCN and NCCN Clinical Practice Guidelines in Oncology™

Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.

E. McLaughlin, P. D. Chakravarty, D. Whittaker, E. Cowan, K. Xu, E. Byrne, D.M. Bruce, J. A. Ford University of Aberdeen.

השמנת יתר חמד " ע פרופ ' ארדון רובינשטין.

The epidemiology of overweight and obesity Katherine M. Flegal, Ph.D. Centers for Disease Control and Prevention National Center for Health Statistics.

Purpose: Serves as guide to accelerate research to reduce the prevalence and burden of obesity, so that people can look forward to healthier lives Enhances.

BINGE EATING AND OBESITY In this power point we will review what binge eating and obesity is how it can harm our health what treatments there are for binge.

MORBID OBESITY A Heavy Burden.... What is Morbid Obesity? A person is classified as morbidly obese when their BMI is greater than 40, or they are more.

Critical Appraisal of Clinical Practice Guidelines

Lookback Module: What you should know 2012 National Conference on Health Statistics Monitoring Health Care Reform through Provider-based Surveys: New Initiatives.

Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.

Linda Snetselaar, PhD, RD Professor Interim Chair of the Department of Community and Behavioral Health College of Public Health University of Iowa.

LESSON 2.8: BODY MASS INDEX Unit 2: Nutrition & Fitness.

Introduction Approximately 1 in 3 of adults, have cardiovascular disease vascular/metabolic risk factors such as hypertension, dyslipidemia, and diabetes;

1 Eduardo Ortiz, M.D., M.P.H. National Heart, Lung, and Blood Institute National Institutes of Health May 10, 2011 IOM Standards for Systematic Reviews:

Cardiovascular Health and Risk Reduction in Children and Adolescents

Chronic Disease Risk Factors: 6th Grade Student Health Screenings Deanna Hanson, MSN RN, BC Beth Whitfield, BSN, RN, MAE Western Kentucky University Fall.

Revealing the Mysteries of Information Mastery Steven R. Brown, MD Banner Good Samaritan Family Medicine Residency December 2010.

Effects of Pediatric Asthma Education on Hospitalizations and Emergency Department Visits: A Meta-Analysis June 3, 2007 Janet M. Coffman, PhD, Michael.

Leveraging Weight Loss in the Treatment of Type 2 Diabetes Part 1 of 4.

10 Points to Remember on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsTreatment of Blood Cholesterol to Reduce.

VA/DoD 2006 Clinical Practice Guideline For Screening and Management of Overweight and Obesity Guideline Summary: Key Elements.

Systematic Reviews.

“Growing Healthy Kids III” Weight-Related Assessment and Management Tools for Youth Maria G. Boosalis, Ph.D., MPH, R.D., L.D. University of Kentucky Division.

1 Evidence Model for Treatment of Overweight and Obesity Cardiovascular Disease Cardiovascular Mortality and Morbidity Noncardiovascular Mortality and.

Background  Obesity is an extremely common problem ~ 1/3 of adult Americans are obese  Patients commonly ask physicians for advice on weight loss, yet.

What Participating Providers Must Tell Consumers.

The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.

Cardiovascular Disease Healthy Kansans 2010 Steering Committee Meeting April 22, 2005.

Presented at the 2006 Annual Scientific Meeting of NAASO, the Obesity Society Boston, Massachusetts October 20–24, 2006 High Prevalence of Misdiagnosis.

CRDAC Questions June 15, 2005 Antihypertensive drugs, with few exceptions, have no outcome claim in their labeling. This is inconsistent with their approval.

1 Georgia Freeman Sherritta Bell 2  The Y.E.A.H. Program’s desire is to create an initiative that will introduce at risk children and their parents.

Fighting Obesity and Inactivity: Role of Parks and Community Siripoom McKay, MD.

Assessing Changes in Diabetes Management and Diabetes Complications in Utah Ladene Larsen, RN Barbara Larsen, RD, MPH William Stinner, Ph.D. Sandra Assasnik,

Thiazide diuretics, Potassium, and the Development of Diabetes A Quantitative Review Hypertension2006_219.

 SC Guidelines for Diabetes Care Screening for Diagnosis of Diabetes To test for diabetes or to assess risk of future diabetes, either A1C, Fasting.

A-1 Introduction Pravastatin-Aspirin 7asdf Fred T. Fiedorek, M.D. Vice President, Clinical Design & Evaluation, Metabolics Pharmaceutical Research Institute.

1 Dissemination and Implementation Paul K. Whelton MD, MSc for the ALLHAT Collaborative Research Group ALLHAT U.S. Department of Health and Human Services.

A Tool Kit for Battling Childhood Obesity:

Measuring the Effect of Obesity on Earnings Xiaoshu Han Department of Economcs.

Chapter 14 Patterns in Health and Disease: Epidemiology and Physiology EXERCISE PHYSIOLOGY Theory and Application to Fitness and Performance, 6th edition.

Overweight Being overweight means having excess body fat for one’s size and build – a condition that will lead to health problems. The main way to address.

Ross T. Tsuyuki, BSc(Pharm), PharmD, MSc, FCSHP, FACC Yazid NJ Al Hamarneh, BPharm, PhD Charlotte Jones, MD, PhD, FRCP(C) Brenda Hemmelgarn, MD, PhD, FRCP(C)

Clara K. Chow, MBBS, PhD; Julie Redfern, PhD; Graham S. Hillis, MBChB, PhD; Jay Thakkar, MBBS; K arla Santo, MBBS; Maree L. Hackett, PhD; Stephen Jan,

OBESITY: A GROWING PROBLEM By: Ashley Vanecek Obesity  A person has traditionally been considered to be obese if they are more than 20 percent over.

Evidence-Based Mental Health PSYC 377. Structure of the Presentation 1. Describe EBP issues 2. Categorize EBP issues 3. Assess the quality of ‘evidence’

Efficacy of Colchicine When Added to Traditional Anti- Inflammatory Therapy in the Treatment of Pericarditis Efficacy of Colchicine When Added to Traditional.

© 2012 Wells Fargo Bank, N.A. All rights reserved. Confidential. Population Health Management Strategy Wells Fargo Insurance Services Chesapeake Health.

2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults by Michael D. Jensen, Donna H. Ryan, Caroline M. Apovian, Jamy D. Ard,

1 Body-Mass Index and Mortality in Korean Men and Women Sun Ha Jee, Ph.D., Jae Woong Sull, Ph.D., Jung yong Park, Ph.D., Sang-Yi Lee, M.D. From the Department.

Date of download: 9/17/2016 From: Effectiveness of Primary Care–Relevant Treatments for Obesity in Adults: A Systematic Evidence Review for the U.S. Preventive.

Multicenter, Placebo-Controlled Trial

Menzies Health Institute Queensland

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.

Near-infrared spectroscopy: What we know and what we need to know—A systematic review of the congenital heart disease literature Jennifer C. Hirsch,

A Quality Improvement Project to Improve the Usage of Universal Lipid Screening Guidelines at a Federally Qualified Health Center in the Southern United.

The Heart Truth Delaware Background

Presentation transcript:

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults NHLBI Obesity Education Initiative National Heart, Lung, and Blood Institute in cooperation with the National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health

2 Background Hypertension Type 2 diabetes Coronary heart disease Gallbladder disease Certain cancers Dyslipidemia Stroke Osteoarthritis Sleep apnea Approximately 108 million American adults are overweight or obese. Increased risk of: CDC/NCHS NHANES 1999

3 Purpose of the Guidelines To provide a thorough review of the scientific evidence on the effects of treatment of overweight and obesity To provide assistance to primary care practitioners on the identification, evaluation, and treatment of overweight and obese patients

4 Charge to the Panel Examine the scientific evidence regarding the issues pertaining to overweight and obesity in adults, particularly those issues related to: —other heart disease risk factors, such as hypertension, blood lipid levels, and diabetes; —the distribution and amount of body fat as it influences risk; —the independent relationship of obesity to coronary heart disease (CHD); and, —the relationship of obesity to sleep apnea.

5 Charge to the Panel (continued) Develop clinical practice guidelines, based on the evidence, for the practicing physician and other health care providers who are dealing with the problem of overweight in the high- risk adult. Make guidelines concise, comprehensive, and easy to use.

6 Obesity Expert Panel Members Diane M. Becker, Sc.D., M.P.H Claude Bouchard, Ph.D. Richard A. Carleton, M.D. Graham Colditz, M.D., Dr.P.H William H. Dietz, M.D., Ph.D. John P. Foreyt, Ph.D. Robert Garrison, Ph.D. Scott Grundy, M.D., Ph.D. Barbara C. Hansen, Ph.D. Millicent Higgins, M.D. James O. Hill, Ph.D. Barbara V. Howard, Ph.D. Robert Kuczmarski, Dr.P.H., R.D. F. Xavier Pi-Sunyer, M.D., M.P.H, Panel Chair

7 Obesity Expert Panel Members Shiriki Kumanyika, Ph.D., M.P.H., R.D. R. Dee Legako, M.D. T. Elaine Prewitt, Dr.P.H., R.D. Albert P. Rocchini, M.D. Philip L. Smith, M.D. Linda Snetselaar, Ph.D., R.D. James R. Sowers, M.D. Michael Weintraub, M.D. David F. Williamson, Ph.D., M.S. G. Terence Wilson, Ph.D.

8 Ex-Officio Panel Members Karen A. Donato, M.S., R.D. Nancy Ernst, Ph.D., R.D. D. Robin Hill, Ph.D. Michael J. Horan, M.D., Sc.M. Van S. Hubbard, M.D., Ph.D. James Kiley, Ph.D. Eva Obarzanek, Ph.D., R.D. Clarice Brown, M.S.

9 Evidence Model for Treatment of Overweight and Obesity Cardiovascular Disease Cardiovascular Mortality and Morbidity Noncardiovascular Mortality and Morbidity Dyslipidemia Glucose Intolerance High Blood Pressure Overweight Individual Treat Kcal Out(( Kcal In )) Abdominal Fat WeightFitness Assess

10 Evidence Model for Treatment of Overweight and Obesity Overweight Individual Treat( Kcal Out) ( Kcal In) Abdominal Fat Weight Dyslipidemia Glucose Intolerance High Blood Pressure Fitness Assess

11 Literature Search Systematic review of published scientific literature in MEDLINE from 1980 through September English language. Priority: randomized controlled trials—394 reviewed. No editorials, letters, or case reports.

12 Inclusion and Exclusion Criteria Timeframe of the study—at least 4 months. For long-term maintenance—1 year or more. Excluded studies with self-reported weights, patients not overweight, dropout rate >35%, or no appropriate control group.

13 Criteria To Evaluate the Evidence A—Strong evidence: Evidence from well- designed randomized controlled trials (or trials that depart only minimally from randomization) that provides a consistent pattern of findings. B—Suggestive evidence (from randomized studies): Evidence as in A, but involving a smaller number of studies and/or a less consistent pattern of findings.

14 Criteria To Evaluate the Evidence (continued) C—Suggestive evidence (from nonrandomized studies): Evidence from the panel’s interpretation of uncontrolled or observational studies. D—Expert judgment: Evidence from clinical experience or experimental research.

15 How Were the Guidelines Developed? NHLBI/NIDDK convened a 24-member expert panel in May Panel reviewed published scientific literature from January 1980 to September Evidence from 394 randomized controlled trials (RCTs) was considered. Data from 236 RCTs were abstracted, and data were compiled into evidence tables. Evidence statements and recommendations were categorized by level of evidence from A to D.